SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study

被引：0
|
作者：
Tongtong Wang
Shrita M. Patel
Anne Hickman
Xinyue Liu
Philip LStJ Jones
Ira Gantz
Carol E. Koro
机构：
[1] Merck & Co.,Department of Pharmacoepidemiology
[2] Inc.,Department of Clinical Safety and Risk Management
[3] Merck & Co.,Department of Global Clinical Development
[4] Inc.,Pharmaceutical Health Services Research, School of Pharmacy
[5] Safety Surveillance and Risk Management,undefined
[6] Pfizer Inc.,undefined
[7] Safety Surveillance and Risk Management,undefined
[8] Pfizer Inc.,undefined
[9] Merck & Co.,undefined
[10] Inc.,undefined
[11] University of Maryland,undefined
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Antihyperglycemic agents; Fournier’s gangrene; Nested case–control study; Sodium–glucose cotransporter 2 inhibitors (SGLT2i); Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：711 / 723
页数：12
相关论文
共 50 条
  • [31] Applications of SGLT2 inhibitors beyond glycaemic control
    O'Hara, Daniel V.
    Lam, Carolyn S. P.
    Mcmurray, John J. V.
    Yi, Tae Won
    Hocking, Samantha
    Dawson, Jessica
    Raichand, Smriti
    Januszewski, Andrzej S.
    Jardine, Meg J.
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (08) : 513 - 529
  • [32] Fournier's gangrene and sodium-glucose cotransporter 2 inhibitors: Is there a causal association?Fournier's?
    Bloomgarden, Zachary
    Einhorn, Daniel
    Grunberger, George
    Handelsman, Yehuda
    JOURNAL OF DIABETES, 2019, 11 (05) : 340 - 341
  • [33] Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors
    Fadini, Gian Paolo
    Sarangdhar, Mayur
    De Ponti, Fabrizio
    Avogaro, Angelo
    Raschi, Emanuel
    BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)
  • [34] SGLT2 INHIBITORS IN KIDNEY TRANSPLANTATION: A MULTICENTER STUDY
    Garcia Carro, Clara
    Bedia Raba, Andrea
    Banegas Deras, Eduardo J.
    Alberto Vigara, Luis
    Valero San Cecilio, Rosalia
    Cruzado Vega, Leonidas
    Gavela, Eva
    Gonzalez Garcia, M. Elena
    Perez-Flores, Isabel
    Sanchez-Bielsa, Francisco
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I884 - I884
  • [35] SGLT2 Inhibitors and Fracture Risk in Individuals with Advanced CKD
    Issa, Rochell
    Fardi, Yasameen
    Brateanu, Andrei
    Negrea, Lavinia Aura
    Dobre, Mirela A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [36] Risk of toe amputation included in PI for SGLT2 inhibitors
    Reactions Weekly, 2017, 1642 (1) : 6 - 6
  • [37] SGLT2 Inhibitors and the Risk of Urogenital Infections: A Concise Review
    Confederat, Luminita-Georgeta
    Dragostin, Oana-Maria
    Condurache, Mihaela-Iustina
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (06)
  • [38] SGLT2 inhibitors increase risk of genital infections and ketoacidosis
    Reactions Weekly, 2021, 1853 (1) : 10 - 10
  • [39] SGLT2 Inhibitors and the Risk of Early Bladder Cancer Events
    Abrahami, Devin
    Tesfaye, Helen
    Yin, Hui
    Yu, Oriana Hoi Yun
    Platt, Robert W.
    Schneeweiss, Sebastian
    Patorno, Elisabetta
    Azoulay, Laurent
    DIABETES, 2022, 71
  • [40] SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis
    Kanbay, Mehmet
    Brinza, Crischentian
    Copur, Sidar
    Sekreter, Ozge
    Burlacu, Alexandru
    Tuttle, Katherine R.
    Rossing, Peter
    Covic, Adrian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
12345